Tumoricidal and anti-angiogenic actions of gamma-linolenic acid and its derivatives.

doi:10.2174/138920106779116892

Paper

Tumoricidal and anti-angiogenic actions of gamma-linolenic acid and its derivatives.

Published Nov 30, 2006 · U. Das

Current pharmaceutical biotechnology

Q2 SJR score

44

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Studies showed that gamma-linolenic acid (GLA) and its derivatives have the potential to be anti-cancer molecules. In vitro, in vivo and limited clinical studies showed that GLA has selective tumoricidal action with little or no side effects. The mechanism of its action appears to be by inducing apoptosis of tumor cells by augmenting free radical generation only in the tumor cells but not normal cells. Intra-arterial injection of a lithium salt derivative of GLA demonstrated its ability to selectively occlude tumor-feeding vessels. Since GLA is an endogenous naturally occurring molecule and has no significant side effects, it calls for more studies to exploit its potential as a novel anti-cancer drug.

Study Snapshot

Gamma-linolenic acid (GLA) shows potential as an anti-cancer agent by inducing apoptosis in tumor cells and selectively occcluding tumor-feeding vessels without significant side effects.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Tumoricidal and anti-angiogenic actions of gamma-linolenic acid and its derivatives.

Sign up to use Study Snapshot

References

Citations

Biomanufacturing of γ-linolenic acid-enriched galactosyldiacylglycerols: Challenges in microalgae and potential in oleaginous yeasts

Engineering oleaginous yeasts, such as Yarrowia lipolytica, for mass production of -linolenic acid-enriched galactosyldiacylglycerols (GDGs-GLA) offers potential for addressing the shortage of GDGs

Nanocomposite zinc oxide@ γ-linolenic acid-canagliflozin-fucoxanthin and/or γ-radiation perturbs key metabolic effectors and suppresses the proliferation of breast cancer cells in vitro

ZLCF nanocomposite with radiotherapy effectively suppresses breast cancer cell proliferation and enhances radiosensitization, making it a promising therapeutic agent for treating breast cancer.

Anti-cancer potential of Tetracarpidium conophorum (African walnut) seed oil on prostate carcinogenesis

Feeding Tetracarpidium conophorum seed oil may slow down prostate cancer development by decreasing COX-2 activity and increasing PPAR-gamma activity.

An evaluation of the phytochemical composition, antioxidant and cytotoxicity of the leaves of Litsea elliptica Blume – An ethnomedicinal plant from Brunei Darussalam

Litsea elliptica leaves show potential cytotoxic activities against carcinoma cells, with mixed leaf extracts showing greater cytotoxicity against A549 cancer cells.

Isolation and purification of glycoglycerolipids to induce apoptosis in breast cancer cells

Cyanobacteria-derived MGDG shows potential in inducing apoptosis in breast cancer cells without significant side effects, warranting further investigation for potential therapeutic applications.

Nanostructured Therapeutic Systems of PUFA'S for the Treatment of Glioblastoma Multiforme.

Nanostructured therapeutic systems loaded with polyunsaturated fatty acids (PUFAs) show potential for effective treatment of glioblastoma multiforme (GBM) and associated diseases due to their cost-effective availability, limited side effects, and insensitivity to drug resistance.

Molecular Biochemical Aspects of Cancer

DNA damage and tumor suppressor gene suppression contribute to the development of cancer, with environmental factors and alterations in proteins playing a significant role in its development.

Biophysical interactions, docking studies and cytotoxic potential of a novel propofol-linolenate: a multi-technique approach

2,6P-ALA shows significant inhibition of cancer cell growth, with its most potent effect on MCF-7 cells, and may transport in blood plasma.

Anticancer activities of fatty acids and their heterocyclic derivatives.

Fatty acid modifications with existing anticancer drugs can potentially make chemotherapy more effective and less toxic, potentially unlocking their true medical potential.